Diabetes Market Research Reports & Industry Analysis

... run in January looking at physician detailing, this week’s FirstWord Physician Views poll investigates which companies are best at physician marketing in the diabetes space. Notably, failure to gain ... endocrinologists, which are the best detailing diabetes companies and drugs and what factors support this view. This week's FirstWord Physician Views poll will ...

... to extend and enhance its market-leading Lantus franchise. At the ADA meeting, Sanofi released the first Phase III data for ... patent expiry date is feasible. In light of recent developments, this week’s Physician Views poll will ask US-based endocrinologists: Whether they anticipate data ...

... of pharmaceutical manufacturers, this week's Physician Views poll will seek feedback from US-based endocrinologists on three key recent developments – discussion regarding pancreatic cancer/pancreatitis ... Physicians View poll will ask US-based endocrinologists: How their prescribing of DPP-4 and GLP-1 products may shift in light of the FDA’s recent assessment ...

... and explains them, helping you stay ahead. Ten ways Diabetes Treatments: World Drug Market 2013-2023 helps you To sum up, then, our ... drugs - discover that industry's overall sales prospects Revenues to 2023 for 7 world-level submarkets - investigate the potential of that industry's components, finding the ...

... growth rates in the more developed markets have declined. IMARC’s new report “Indian Diabetes Market Report: Epidemiology, Patients, Prevalence, Oral Anti- ... , demographical breakup, diagnosis and treatment of diabetes in India. The report has segmented the Indian diabetes market into three segments

This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fueled by an increasing number ...

... refractory patients– each of these segments carries ~$1b opportunity to Takeda. In this report, we have analyze TAK-875 market positioning and model, target segments, therapy ...

Turn of The Decade: Novel Glp-1’s To Emerge as the New Leader in Diabetes Class Bydureon – A near term growth driver of the class Novel delivery platforms and fixed ... in cumulative peak sales for this class of drugs by the turn of this decade as we see innovation efforts around this class will result in ...

Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,200.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 Diabetes has emerged as one of the most common diseases in China, affecting...

IMARC’s new report “Japan Diabetes Market Report & Forecast 2011-2016” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future tre...

Product description The present Competitive Intelligence Report about Targeted Therapy of Diabetes provides a competitor evaluation in the field of novel molecules being developed for treatment of type 1 and 2 diabetes as of April 2011. Major pharmacologic approaches include insulin, PPAR agonists, DPP-IV ...

Single User PDF Format: US$ 800.00 Multi-User License: US$ 1,200.00 Hard Copy: US$ 900.00 CD-ROM: US$ 900.00 Diabetes is the world’s most costly epidemic. It is anticipated that, over...

Price (Single User PDF): $2,995.00 Price (Global Site License): $5,990.00 This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the...

Life Science Analytics', Type I Diabetes Therapy Area Pipeline Report contains detailed information on the type i diabetes drug pipeline. This report provides insight into the pipeline status of type...

Life Science Analytics', Type II Diabetes Therapy Area Pipeline Report contains detailed information on the type ii diabetes drug pipeline. This report provides insight into the pipeline status of typ...

As the second largest economy of the world, China enjoys pink of health but its affluence is giving rise to another sickness- a rapid increase in a life-style disease called diabetes. With the Chinese...

With around 51 Million diabetes patients, India promises to be amongst the most lucrative diabetes markets in the world. In 2009, the total sales of Insulin and Non-Insulin Anti-diabetics reached US$...

Life Science Analytics', Type I Diabetes Therapy Area Pipeline Report contains detailed information on the type i diabetes drug pipeline. This report provides insight into the pipeline status of type...

Life Science Analytics', Type II Diabetes Therapy Area Pipeline Report contains detailed information on the type ii diabetes drug pipeline. This report provides insight into the pipeline status of typ...